Demonstration of changes in plasma cell subsets in multiple myeloma

Haematologica

Volumn 92, Issue 8, 2007, Pages 1135-1138

  Ayliffe, Michael John ^a   Davies, Faith Elizabeth ^b   De Castro, David ^b   Morgan, Gareth John ^b  

^a ST HELIER HOSPITAL   (United Kingdom)

^b INSTITUTE OF CANCER RESEARCH   (United Kingdom)

Author keywords

Bone marrow; Free light chains; Monoclonal immunoglobulins; Multiple myeloma; Plasma cells

Indexed keywords

PARAPROTEIN; IMMUNOGLOBULIN HEAVY CHAIN; IMMUNOGLOBULIN LIGHT CHAIN;

ADULT; AGED; ARTICLE; BONE MARROW; CANCER GROWTH; CANCER SURVIVAL; CELL POPULATION; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN CELL; IMMUNOFLUORESCENCE; MALE; MULTIPLE MYELOMA; PLASMA CELL; AMYLOIDOSIS; CELL COUNT; CHEMISTRY; CLASSIFICATION; COMPARATIVE STUDY; DISEASE COURSE; FLUORESCENCE MICROSCOPY; MIDDLE AGED; PARAPROTEINEMIA; PATHOLOGY; PLASMA CELL LEUKEMIA; PLASMACYTOMA; RETROSPECTIVE STUDY; WALDENSTROEM MACROGLOBULINEMIA;

ADULT; AGED; AMYLOIDOSIS; BONE MARROW; CELL COUNT; DISEASE PROGRESSION; FEMALE; HUMANS; IMMUNOGLOBULIN HEAVY CHAINS; IMMUNOGLOBULIN LIGHT CHAINS; LEUKEMIA, PLASMACYTIC; MALE; MICROSCOPY, FLUORESCENCE; MIDDLE AGED; MULTIPLE MYELOMA; MYELOMA PROTEINS; PARAPROTEINEMIAS; PLASMA CELLS; PLASMACYTOMA; RETROSPECTIVE STUDIES; WALDENSTROM MACROGLOBULINEMIA;

EID: 35748983242     PISSN: 03906078     EISSN: None     Source Type: Journal    
DOI: 10.3324/haematol.11133     Document Type: Article

References (11)

1. Mead GP, Carr-Smith HD, Drayson MT, Morgan GJ, Child JA, Bradwell AR. Serum free light chains for monitoring multiple myeloma. Br J Haematol 2004;126:348-54.
2. Rajkumar SV, Kyle RA, Therneau TM, Clark RJ, Bradwell AR, Melton LJ, et al. Presence of monoclonal free light chains in the serum predicts risk of progression in monoclonal gammopathy of undetermined significance. Br J Haematol 2004;127:308-10.
3. Kyle RA, Gertz MA, Witzig TE, Lust JA, Lacy MQ, Dispenzieri A, et al. Review of 1027 cases with newly diagnosed multiple myeloma. Mayo Clin Proc 2003;78:21-33.
4. Bradwell AR, Carr-Smith HD, Mead GP, Harvey TC, Drayson MT. Serum test for assessment of cases with Bence Jones MM. Lancet 2003;361:489-91.
5. Ayliffe MJ. Double staining immunofluorescence procedure for enumeration of cells containing cytoplasmic immunoglobulin in human bone marrow. 40 selected cases. J Clin Pathol 1985;38:989-94.
6. Greipp PR, Lust JA, O'Fallon WM, Katzmann JA, Witzig TE, Kyle RA. Plasma cell labelling index and β2-microglobulin predict survival independent of thymidine kinase and C-reactive protein in multiple MM. Blood 1993;81:3382-7.
7. Rajkumar SV, Fonseca R, Lacy MQ, Witzig TE, Therneau TM, Kyle RA, et al. Plasmablastic morphology is an independent predictor of poor survival after autologous stem-cell transplantation for multiple MM. J Clin Oncol 1999;17:1551-7.
8. Durie BGM, Harousseau J-L, MIguel JS, Blade J, Barlogie B, Anderson K, et al. International uniform response criteria for multiple MM. Leukaemia 2006;9:1467-73.
9. Hobbs JR. Growth rates and responses to treatment in human myelomatosis. Br J Haematol 1969; 16:607-17.
10. Kunnemund A, Liebisch P, Bauchmuller K, Haas P, Kieber M, Bisse E, et al, Secondary light chain multiple MM with decreasing IgA paraprotein levels correlating with renal insufficiency and progressive disease: clinical course of two cases and review of the literature. Onkologie 2005;28 Suppl 3:165.
11. Dawson MA, Patil S, Spencer A. Extramedullary relapse of multiple myeloma associated with a shift in secretion from intact immunoglobulin to light chains. Haematologica 2007;92:143-4.